Kidney Cancer :: B.C. first to fund new drug therapies for kidney cancer
Patients with advanced kidney cancer and gastrointestinal stromal tumours in British Columbia will be the first in Canada to benefit from coverage for the medication Sutent (sunitinib) or Nexavar (sorafenib), announced Health Minister George Abbott today.